A New Angiographic Risk Score in Facilitated PCI

Slides:



Advertisements
Similar presentations
The EMERALD Trial Diabetic Substudy. EMERALD Diabetic Analysis To compare myocardial perfusion and infarct sizes in diabetic and non-diabetic patients.
Advertisements

Early Impaired Myocardial Perfusion is Associated with Larger SPECT Infarct Size Patients with a closed myocardium (TMPG 0/1) and patients without complete.
STOPAMI 1 & 2 Predictive Factors and Impact of No-Reflow After Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction.
Protection Devices in PCI-Treatment of Myocardial Infarction for Salvage of Endangered Myocardium Study Presented at American College of Cardiology Scientific.
Unstable Angina: Embolism Can Occur Prior to PCI Thrombus in proximal RCA Stain of muscle before injection begins: TIMI Myocardial perfusion grade 1 CM.
Intracoronary Serotonin and Endothelin Release After PCI / Stenting Taylor AJ. Am Heart J Aug;148(2): e10 Leosco et al, AJC 1999;84:
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
The AiMI Trial Arshad Ali, MD, David Cox, MD, Nabil Dib, MD, Bruce Brodie, MD, Daniel Berman, MD, Navin Gupta, MD, Kevin Browne, MD, Robert Iwaoka, MD,
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
Clinical Trial Results. org C. Michael Gibson, M.S., M.D. Director TIMI Data Coordinating Center Invasive Cardiologist Beth Israel Deaconess Medical Center.
Angiographic Estimates of Myocardium at Risk During Acute Myocardial Infarction: a Validation Study Using Cardiac MRI José T. Ortiz, Sheridan N. Meyers,
Beyond TIMI 3 Flow CTFC < 14 CTFC > % (n=41) (n = 18/640) (n =35/563) 2.8% p= “TIMI 4” Flow TIMI 3 Flow 14 < CTFC < % % Risk of In Hospital.
RP Giugliano MD, SM; MT Roe, MD, MHS; RA Harrington MD; CM Gibson, MS, MD; U Zeymer, MD; F Van de Werf, MD, PhD; KW Baran, MD; HP Hobbach, MD; LH Woodlief,
The 90 Minute Wall: 60% Rates of TIMI Grade 3 Flow % TIMI 3 Flow.
UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Infarct transmurality and infarct size assessed by delayed enhancement magnetic resonance imaging: Association.
LESSON 1 LESSON 1 Establishment of:
PROTECT: What Have We Learned Lesson 2: TMPG is associated with clinical and biomarker outcomes following PCI.
Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Anti-Platelet and Anti-Thrombotic.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: When to stress patients after coronary artery bypass.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Value of Platelet Reactivity in Predicting Response.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of Multislice Computed Tomography.
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic.
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
Randomized Early versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial) Mauro Maioli, MD, Francesco.
Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between heparin anticoagulation and.
Date of download: 7/11/2016 Copyright © The American College of Cardiology. All rights reserved. From: Small molecule glycoprotein IIb/IIIa receptor inhibitors.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.
Total Occlusion Study of Canada (TOSCA-2) Trial
IABP-SHOCK II Score Stratifies Patient Risk in CS after AMI
Risk stratification in ACS F.Shakib .cardiologigst
Figure 2 Kaplan–Meier estimates of event-free survival (survival to the combined endpoint). From: Long-term outcomes of patients with acute myocardial.
Intra Coronary AdjunctivE Tenecteplase During Primary PCI for STEMI:
Presenter Disclosure Information
Circ Cardiovasc Interv
Effect of Obesity on In-Hospital Mortality in Patients with Cardiogenic Shock Complicating AMI Obesity is paradoxically associated with favorable mortality.
No Reflow Reflow P value Arrhythmia 40% 18% Lecture Notes
ATLANTIC Trial design: Participants with STEMI being transported for primary PCI were randomized in the ambulance to ticagrelor 180 mg (n = 909) vs. placebo.
European Society of Cardiology 2003
Nat. Rev. Cardiol. doi: /nrcardio
Fewer PCIs After Public Reporting Changes in NY
PROTECT – TIMI 30 Trial Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Anti-Platelet.
Published in the European Heart Journal
In STEMI Complete Reperfusion (TFG 3, TMPG 3, ST Res  70%) is Associated with a Greater Percent of Receptors Occupied by Integrilin 52.0% % Pts With Complete.
Myocardial Staining (TMPG 1)  Post-Stent in AMI
52.0% Complete Resolution TFG 3 TMPG 3 ST Resolution  70% p=0.006
PROTECT: What Have We Learned
TIMI Myocardial Perfusion (TMP) Grades Dye strongly persistent
Role of Stenting in Acute MI: PAMI Stent Pilot Trial
Mancini JG, et al. Am J Cardiol.
Nat. Rev. Cardiol. doi: /nrcardio
Dye strongly persistent
Ischemic Postconditioning
Overall (n=301) Acute/Subacute (n=149) Late (n=152) p Presentation
Nat. Rev. Cardiol. doi: /nrcardio
Dye strongly persistent
Association of Troponin Elevation with Risk of Mortality in Acute Coronary Syndromes Mortality at 42 Days  % A study by Antman and.
European Heart Journal Advance Access
MRI Hyperenhancement is Associated with Myonecrosis Following PCI
INTRO AMI. INTEGRILIN AND. REDUCED DOSE. OF THROMBOLYTIC IN. ACUTE
Evolution of Myocardial Blush after MI
GUSTO 1 Trial 41,000 patients enrolled, landmark study
ESPRIT INTEGRITI TACTICS Rate of Increase in DSA
Dye strongly persistent
Presentation transcript:

A New Angiographic Risk Score in Facilitated PCI Integrates epicardial and tissue level perfusion Integrates flow before and after PCI Simply total the following: TIMI Flow Grade Before PCI (0-3) TIMI Myocardial Perfusion Grade Before PCI (0-3) TIMI Flow Grade After PCI (0-3) TIMI Myocardial Perfusion Grade After PCI (0-3) Total Angiographic Risk Score: 0 - 12 Gibson CM, AHJ 2004

Relationship of Angiographic Perfusion Score to SPECT Infarct Size & Mortality 35.5% 11.1% p=0.002 p=0.01 % SPECT Infarct Size % Death by 30 days 16.2% 12.5% 1.9% 0.0% Angiographic Perfusion Score Gibson CM, AHJ 2004

Further Risk Stratification Provided by the TMPG among Patients with TIMI 3 Flow or TIMI 2/3 flow Martinez-Rios MA, Am J Cardiol 2004;93:280–287.

Combining TIMI Flow and Perfusion Grades Martinez-Rios MA, Am J Cardiol 2004;93:280–287.

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.